back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-12-20 13:39 Tx date 2024-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+18,709 vol |
18,709 | |
| Filed 2024-12-20 13:35 Tx date 2024-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-16,000 vol |
373,000 | |
| Filed 2024-12-20 13:31 Tx date 2024-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-9,334 vol |
389,000 | |
| Filed 2024-12-20 13:28 Tx date 2024-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-474,096.90
-11,510 vol $41.19 each |
0 | |
| Filed 2024-12-20 13:27 Tx date 2024-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-185,347.20
-4,490 vol $41.28 each |
11,510 | |
| Filed 2024-12-20 13:26 Tx date 2024-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$185,280
+16,000 vol $11.58 each |
16,000 | |
| Filed 2024-12-20 13:24 Tx date 2024-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-296,814.77
-7,199 vol $41.23 each |
0 | |
| Filed 2024-12-20 13:21 Tx date 2024-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-88,132.80
-2,135 vol $41.28 each |
7,199 | |
| Filed 2024-12-20 13:19 Tx date 2024-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$88,112
+9,334 vol $9.44 each |
9,334 | |
| Filed 2023-03-14 17:04 Tx date 2023-03-10 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+120,000 vol |
398,334 | |
| Filed 2022-09-07 16:42 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-607,597.35
-15,355 vol $39.57 each |
0 | |
| Filed 2022-09-07 16:41 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,293 vol |
15,355 | |
| Filed 2022-09-07 16:40 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+6,511 vol |
18,648 | |
| Filed 2022-09-07 16:40 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+2,292 vol |
12,137 | |
| Filed 2022-09-07 16:39 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+813 vol |
9,845 | |
| Filed 2022-09-07 16:38 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+32 vol |
9,032 | |
| Filed 2022-09-07 16:38 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+9,000 vol |
9,000 | |
| Filed 2022-09-07 16:37 Tx date 2021-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-07 16:35 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-30,927.25
-6,511 vol $4.75 each |
278,334 | |
| Filed 2022-09-07 16:35 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,105.20
-2,292 vol $3.10 each |
284,845 | |
| Filed 2022-09-07 16:33 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,829.20
-813 vol $8.40 each |
287,137 | |
| Filed 2022-09-07 16:32 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-239.68
-32 vol $7.49 each |
287,950 | |
| Filed 2022-09-07 16:30 Tx date 2022-09-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-84,960
-9,000 vol $9.44 each |
287,982 | |
| Filed 2022-03-14 17:11 Tx date 2022-03-10 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
296,982 | |
| Filed 2021-06-03 18:42 Tx date 2021-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,855,999
+100,000 vol $18.56 each |
171,982 | |
| Filed 2021-06-03 18:40 Tx date 2021-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Aulin, Sherry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
71,982 |